IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shubitz, L.
Right arrow Articles by Galgiani, J. N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shubitz, L.
Right arrow Articles by Galgiani, J. N

 Previous Article  |  Next Article 

Infection and Immunity, June 2002, p. 3287-3289, Vol. 70, No. 6
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.6.3287-3289.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Protection of Mice against Coccidioides immitis Intranasal Infection by Vaccination with Recombinant Antigen 2/PRA

Lisa Shubitz,1,2 Tao Peng,1,2,3 Robert Perrill,1,2 Julie Simons,1,2 Kris Orsborn,1,2,3 and John N Galgiani1,2,3,4*

Valley Fever Center for Excellence,1 Medicine and Subspecialties Program,4 Research Program, Southern Arizona Veterans Affairs Health Care System,2 Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona 857233

Received 2 October 2001/ Returned for modification 26 December 2001/ Accepted 21 March 2002

Subcutaneous vaccination with recombinant antigen 2/PRA (rAg2/PRA) protected BALB/c mice against intranasal infection with Coccidioides immitis. Subcutaneously vaccinated C57BL/6 mice and intranasally vaccinated BALB/c mice were protected against larger numbers of infecting spores. Weight loss correlated with lethality, but histologic appearance did not. These studies support rAg2/PRA vaccination to prevent coccidioidomycosis.

* Corresponding author. Mailing address: Valley Fever Center for Excellence 3601 South Sixth Ave., Tucson, AZ 85723. Phone: (520) 629-4777. Fax: (520) 629-4738. E-mail: spherule{at}u.arizona.edu.

Editor: T. R. Kozel

Infection and Immunity, June 2002, p. 3287-3289, Vol. 70, No. 6
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.6.3287-3289.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2002 by the American Society for Microbiology. All rights reserved.